- Home
- CNTX vs BDSX Comparison
CNTX vs BDSX Comparison
Compare CNTX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- BDSX
- Stock Information
- Founded
- CNTX 2015
- BDSX 2005
- Country
- CNTX United States
- BDSX United States
- Employees
- CNTX N/A
- BDSX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- BDSX Precision Instruments
- Sector
- CNTX Health Care
- BDSX Health Care
- Exchange
- CNTX Nasdaq
- BDSX Nasdaq
- Market Cap
- CNTX 75.6M
- BDSX 61.9M
- IPO Year
- CNTX 2021
- BDSX 2020
- Fundamental
- Price
- CNTX $1.13
- BDSX $7.36
- Analyst Decision
- CNTX Strong Buy
- BDSX Strong Buy
- Analyst Count
- CNTX 7
- BDSX 5
- Target Price
- CNTX $5.20
- BDSX $32.50
- AVG Volume (30 Days)
- CNTX 260.4K
- BDSX 122.1K
- Earning Date
- CNTX 11-05-2025
- BDSX 10-31-2025
- Dividend Yield
- CNTX N/A
- BDSX N/A
- EPS Growth
- CNTX N/A
- BDSX N/A
- EPS
- CNTX N/A
- BDSX N/A
- Revenue
- CNTX N/A
- BDSX $76,556,000.00
- Revenue This Year
- CNTX N/A
- BDSX $18.80
- Revenue Next Year
- CNTX N/A
- BDSX $27.76
- P/E Ratio
- CNTX N/A
- BDSX N/A
- Revenue Growth
- CNTX N/A
- BDSX 25.70
- 52 Week Low
- CNTX $0.49
- BDSX $3.44
- 52 Week High
- CNTX $2.59
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- CNTX 69.12
- BDSX 68.31
- Support Level
- CNTX $0.98
- BDSX $7.36
- Resistance Level
- CNTX $1.29
- BDSX $7.95
- Average True Range (ATR)
- CNTX 0.09
- BDSX 0.58
- MACD
- CNTX 0.02
- BDSX -0.16
- Stochastic Oscillator
- CNTX 65.91
- BDSX 48.31
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.